Chemokine receptor CXCR4: Role in gastrointestinal cancer

Critical Reviews in Oncology/Hematology

Volumn 88, Issue 3, 2013, Pages 696-705

  Lombardi, Lucia ^a   Tavano, Francesca ^a   Morelli, Franco ^a   Latiano, Tiziana Pia ^a   Di Sebastiano, Pierluigi ^a,b   Maiello, Evaristo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b SS Annunziata Hospital   (Italy)

Author keywords

Chemokine; CXCR4 SDF 1; Gastrointestinal cancer; Immunology; Therapy; Tumor microenvironment

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

CALCIUM CELL LEVEL; CANCER CELL; CANCER GROWTH; CANCER IMMUNOLOGY; CELL ADHESION; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CHEMOTAXIS; DIGESTIVE SYSTEM CANCER; ENDOTHELIUM CELL; EPITHELIUM CELL; EXTRAVASATION; FIBROBLAST; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; INTRACELLULAR SIGNALING; LEUKOCYTE ACTIVATION; METASTASIS; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ESCAPE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

CHEMOKINE; CXCR4/SDF-1; GASTROINTESTINAL CANCER; IMMUNOLOGY; THERAPY; TUMOR MICROENVIRONMENT;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINE CXCL12; GASTROINTESTINAL NEOPLASMS; HUMANS; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84888294650     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2013.08.005     Document Type: Review

References (85)

1. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
2. Struyf S., Proost P., Van Damme J. Regulation of the immune response by the interaction of chemokines and proteases. Advances in Immunology 2003, 81:1-44.
3. Ransohoff R.M. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 2009, 31(5):711-721.
4. Lazennec G., Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends in Molecular Medicine 2010, 16:133-144.
5. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nature Immunology 2001, 2:123-128.
6. Zlotnik A. Involvement of chemokine receptors in organspecific metastasis. Contributions to Microbiology 2006, 13:191-199.
7. Loetscher P., Moser B., Baggiolini M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Advances in Immunology 2000, 74:127-180.
8. Burger J.A., Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
9. Zlotnik A. Chemokines and cancer. International Journal of Cancer 2006, 119:2026-2029.
10. Fredriksson R., Lagerstrom M.C., Lundin L.G., Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Molecular Pharmacology 2003, 63:1256-1272.
11. Nagasawa T., Hirota S., Tachibana K., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
12. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
13. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annual Review of Immunology 1994, 12:593-633.
14. Meads M.B., Hazlehurst L.A., Dalton W.S. The bone marrow microenvironment as a tumour sanctuary and contributor to drug resistance. Clinical Cancer Research 2008, 14:2519.
15. Keeley E.C., Mehrad B., Strieter R.M. Cxc chemokines in cancer angiogenesis and metastases. Advances in Cancer Research 2010, 106:91-111.
16. Kruizinga R.C., Bestebroer J., Berghuis P., et al. Role of chemokines and their receptors in cancer. Current Pharmaceutical Design 2009, 15:3396-3416.
17. Zou Y.R., Kottmann A.H., Kuroda M., et al. Function of the chemokine receptor cxcr4 in haematopoiesis and in cerebellar development. Nature 1998, 393(6685):595-599.
18. Aiuti A., Tavian M., Cipponi A., et al. Expression of cxcr4, the receptor for stromal cell-derived factor-1 on fetal and adult human lymphohematopoietic progenitors. European Journal of Immunology 1999, 29(6):1823-1831.
19. Secchiero P., Celeghini C., Cutroneo G., Di Baldassarre A., Rana R., Zauli G. Differential effects of stromal derived factor-1 alpha (sdf-1 alpha) on early and late stages of human megakaryocytic development. The Anatomical Record 2000, 260(2):141-147.
20. Wright L.M., Maloney W., Yu X., Kindle L., Collin-Osdoby P., Osdoby P. Stromal cell-derived factor-1 binding to its chemokine receptor cxcr4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Bone 2005, 36(5):840-853.
21. Gillette J.M., Larochelle A., Dunbar C.E., Lippincott-Schwartz J. Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche. Nature Cell Biology 2009, 11(3):303-311.
22. Kyriakou C., Rabin N., Pizzey A., Nathwani A., Yong K. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 2008, 93(10):1457-1465.
23. Dettin M., Pasquato A., Scarinci C., Zanchetta M., De Rossi A., Di Bello C. Anti-HIV activity and conformational studies of peptides derived from the c-terminal sequence of sdf-1. Journal of Medicinal Chemistry 2004, 47(12):3058-3064.
24. Janowski M. Functional diversity of sdf-1 splicing variants. Cell Adhesion & Migration 2009, 3(3):243-249.
25. Kucia M., Wojakowski W., Reca R., et al. The migration of bone marrow-derived non-hematopoietic tissue-committed stem cells is regulated in an sdf-1-, hgf-, and life-dependent manner. Archivum Immunologiae et Therapiae Experimentalis 2006, 54(2):121-135.
26. Neiva K., Sun Y.X., Taichman R.S. The role of osteoblasts in regulating hematopoietic stem cell activity and tumor metastasis. Brazilian Journal of Medical and Biological Research 2005, 38(10):1449-1454.
27. Jung Y., Wang J., Schneider A., et al. Regulation of sdf-1 (cxcl12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 2006, 38(4):497-508.
28. Gupta S.K., Pillarisetti K. Cutting edge: cxcr4-lo: molecular cloning and functional expression of a novel human cxcr4 splice variant. Journal of Immunology 1999, 163(5):2368-2372.
29. Wegner S.A., Ehrenberg P.K., Chang, et al. Genomic organization and functional characterization of the chemokine receptor cxcr4, a major entry co-receptor for human immunodeficiency virus type 1. The Journal of Biological Chemistry 1998, 273(8):4754-4760.
30. Aiuti A., Webb I.J., Bleul C., Springer T., Gutierrez-Ramos J.C. The chemokine sdf-1 is a chemoattractant for human cd34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of cd34+ progenitors to peripheral blood. The Journal of Experimental Medicine 1997, 185(1):111-120.
31. Psenak O. Stromal cell-derived factor 1 (SDF-1). Its structure and function. Casopis Lekaru Ceskych 2001, 140:355-363.
32. Phillips R.J., Burdick M.D., Lutz M., Belperio J.A., Keane M.P., Strieter R.M. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. American Journal of Respiratory and Critical Care Medicine 2003, 167:1676-1686.
33. Schmitt N., Chene L., Boutolleau D., et al. Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication. Journal of Virology 2003, 77:5784-5793.
34. Rempel S.A., Dudas S., Ge S., Gutierrez J.A. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clinical Cancer Research 2000, 6:102-111.
35. Nanki T., Lipsky P.E. Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. Journal of Immunology 2000, 164:5010-5014.
36. Suzuki Y., Rahman M., Mitsuya H. Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects ofSDF-1 on CD4(+) T cells. Journal of Immunology 2001, 167:3064-3073.
37. Colamussi M.L., Secchiero P., Gonelli A., Marchisio M., Zauli G., Capitani S. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional upregulation of the Fas (CD95)/Fas ligand (CD95L) pathway. Journal of Leukocyte Biology 2001, 69:263-270.
38. Vianello F., Papeta N., Chen T., et al. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. Journal of Immunology 2006, 176:2902-2914.
39. Dunussi-Joannopoulos K., Zuberek K., Runyon K., et al. Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses. Blood 2002, 100:1551-1558.
40. Lee C.H., Kakinuma T., Wang J., et al. Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases. Molecular Cancer Therapeutics 2006, 5:2592-2599.
41. Balkwill F. Cancer and the chemokine network. Nature Reviews Cancer 2004, 4:540-550.
42. Mantovani A., Allavena P., Sozzani S., Vecchi A., Locati M., Sica A. Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Seminars in Cancer Biology 2004, 14:155-160.
43. Opdenakker G., Van Damme J. The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines. International Journal of Developmental Biology 2004, 48:519-527.
44. Biswas S.K., Sica A., Lewis C.E. Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. Journal of Immunology 2008, 180:2011-2017.
45. Wallace M.E., Smyth M.J. The role of natural killer cells in tumor control-effectors and regulators of adaptive immunity. Seminars in Immunopathology 2005, 27:49-64.
46. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005, 438:932-936.
47. Hillen F., Griffioen A.W. Tumour vascularization: sprouting angiogenesis and beyond. Cancer and Metastasis Reviews 2007, 26:489-502.
48. Liekens S., Bronckaers A., Perez-Perez M.J., Balzarini J. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy. Biochemical Pharmacology 2007, 74:1555-1567.
49. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Annals of Surgery 1972, 175:409-416.
50. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410(6824):50-56.
51. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Seminars in Cancer Biology 2004, 14:171-179.
52. Smith M.C., Luker K.E., Garbow J.R., et al. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Research 2004, 64:8604-8612.
53. Scotton C.J., Wilson J.L., Scott K., et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Research 2002, 62:5930-5938.
54. Pan J., Mestas J., Burdick M.D., et al. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Molecular Cancer 2006, 5:56.
55. Taichman R.S., Cooper C., Keller E.T., Pienta K.J., Taichman N.S., McCauley L.K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Research 2002, 62:1832-1837.
56. Geminder H., Sagi-Assif O., Goldberg L., et al. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cellderived factor-1, in the development of bone marrow metastases in neuroblastoma. Journal of Immunology 2001, 167:4747-4757.
57. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
58. Schioppa T., Uranchimeg B., Saccani A., et al. Regulation of the chemokine receptor CXCR4 by hypoxia. Journal of Experimental Medicine 2003, 198:1391-1402.
59. Staller P., Sulitkova J., Lisztwan J., Moch H., Oakeley E.J., Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003, 425:307-311.
60. Chu C.Y., Cha S.T., Chang C.C., et al. Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1 alpha directed invasion of human basal cell carcinoma cells. Oncogene 2007, 26:2491-2501.
61. Roland J., Murphy B.J., Ahr B., et al. Role of the intracellular domains of cxcr4 in sdf-1-mediated signaling. Blood 2003, 101:399-406.
62. Zhang X.F., Wang J.F., Matczak E., Proper J., Groopman J.E. Janus kinase 2 is involved in stromal cell-derived factor-1α-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood 2001, 97:3342-3348.
63. Gockel I., Schimanski C.C., Heinrich C., et al. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. BMC Cancer 2006, 6:290.
64. Yasumoto K., Koizumi K., Kawashima A., et al. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Research 2006, 66:2181-2187.
65. Billadeau D.D., Chatterjee S., Bramati, et al. Characterization of the cxcr4 signaling in pancreatic cancer cells. International Journal of Gastrointestinal Cancer 2006, 37(4):110-119.
66. Mori T., Doi R., Koizumi M., et al. Cxcr4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Molecular Cancer Therapeutics 2004, 3(1):29-37.
67. Marchesi F., Monti P., Leone B.E., et al. Increased survival, proliferation, and migration in metastatic human pancreatic tumour cells expressing functional cxcr4. Cancer Research 2004, 64(22):8420-8427.
68. Gao Z., Wang X., Wu K., Zhao Y., Hu G. Pancreatic stellate cells increase the invasion of human pancreatic cancer cells through the stromal cell-derived factor-1/cxcr4 axis. Pancreatology 2010, 10(2-3):186-193.
69. Hermann P.C., Huber S.L., Herrler T., et al. Distinct populations of cancer stem cells determine tumour growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007, 1:313-323.
70. Schimanski C.C., Bahre R., Gockel I., et al. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. British Journal of Cancer 2006, 95:210-217.
71. Sutton A., Friand V., Brulé-Donneger S., et al. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Molecular Cancer Research 2007, 5:21-33.
72. Liu H., Pan Z., Li A., et al. Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Cellular & Molecular Immunology 2008, 5:373-378.
73. Kim J., Mori T., Chen S.L., et al. Chemokine receptor cxcr4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Annals of Surgery 2006, 244:113-120.
74. Zeelenberg I.S., Ruuls-Van Stalle L., Roos E. The chemokine receptor cxcr4 is required for outgrowth of coloncarcinoma micrometastases. Cancer Research 2003, 63(13):3833-3839.
75. Liang Z., Yoon Y., Liang Z., et al. Silencing of cxcr4 blocks breast cancer metastasis. Cancer Research 2005, 65:967-971.
76. Hojo S., Koizumi K., Tsuneyama K., et al. High-level expression of chemokine cxcl16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Research 2007, 67(10):4725-4731.
77. Hartmann T.N., Grabovsky V., Pasvolsky R., et al. A crosstalk between intracellular cxcr7 and cxcr4 involved in rapid cxcl12-triggered integrin activation but not in chemokine-triggered motility of human t lymphocytes and cd34+ cells. Journal of Leukocyte Biology 2008, 84(4):1130-1140.
78. Wysoczynski M., Miekus K., Jankowski K., et al. Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Research 2007, 67(5):2131-2140.
79. McGrath K.E., Koniski A.D., Maltby K.M., McGann J.K., Palis J. Embryonic expression and function of the chemokine sdf-1 and its receptor, cxcr4. Developmental Biology 1999, 23(2):442-456.
80. Kukreja P., Abdel-Mageed A.B., Mondal D., Liu K., Agrawal K.C. Up-regulation of CXCR4 expression in PC-3 cells by stromal derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: Role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Research 2005, 65:9891-9898.
81. Darash-Yahana M., Pikarsky E., Abramovitch R., et al. Role of high expression levels of CXCR4 in tumour growth, vascularization and metastasis. FASEB Journal 2004, 18:1240-1242.
82. Engl T., Relja B., Marian D., et al. CXCR4 chemokine receptor mediates prostate tumour cell adhesion through alpha5 and beta3 integrins. Neoplasia 2006, 8:290-301.
83. Xing Y., Liu M., Du Y., et al. Tumour cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: a possible metastasis preventing and minimizing approach. Cancer Biology and Therapy 2008, 7:1839-1848.
84. Zhang W.B., Navenot J.M., Haribabu B., et al. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists. Journal of Biological Chemistry 2002, 277:24515-24521.
85. Zeelenberg I.S., Ruuls-Van Stalle L., Roos E. Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma. Journal of Clinical Investigation 2001, 108:269-277.